市場調查報告書
商品編碼
1241363
動物感染疾病診斷的全球市場:現狀分析、預測 (2022年~2028年)Global Veterinary Infectious Disease Diagnostics Market: Current Analysis and Forecast (2022-2028) |
由於動物傳染病很難診斷,因此進行了廣泛的研究,這推動了動物傳染病診斷市場的成長。此外,飼養動物數量增加和傳染病的流行也促進了市場的成長。由於私營公司和政府之間的合作,預計動物傳染病診斷市場將以8%左右的速度穩定成長。
本報告提供全球動物感染疾病診斷的市場調查,市場定義和概要,市場成長的各種影響因素分析,市場規模的變化、預測,各種區分、各地區/主要國家的明細,法律制度,供需趨勢,競爭環境,主要企業簡介等彙整資訊。
Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. The frequently occurring infectious diseases in animals are avian influenza virus and rabies virus. The diagnosis of infectious diseases is extremely difficult owing to the lack of symptoms in the animals. Therefore, huge research has been done in the sector, thus driving the growth of the market. Moreover, The rising adoption of animals and the increasing prevalence of infectious diseases among them are attributed to the market growth of the veterinary infectious disease diagnostics market. For instance, according to the Centers for Disease Control (CDC), Scientists estimate that more than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new or emerging infectious diseases in people come from animals.
The Veterinary Infectious Disease Diagnostics Market is expected to grow at a steady rate of around 8% owing to the collaboration of private companies and governments. For instance, in January 2023, Alveo Technologies and the government of Barbados collaborate to co-develop advanced molecular disease diagnostics across multiple end markets.
Based on the technology, the market has been categorized into immunodiagnostics, molecular diagnostics, and others. Among them, the immunodiagnostics segment held a dominant share of the market in 2021. Immunodiagnostics is a technique of detection by using the ability of antibodies to bind to an antigen specifically. Factors such as the high efficiency of the technique, its cost-effective method of diagnostics, and it provides fast results are responsible for the dominating share of the segment.
Based on the animal type, the market has been categorized into companion animals and food-producing animals. Among them, the companion animals segment is anticipated to witness the fastest growth in the market. The increasing adoption of the companion animals such as dogs and cats is an important reason for the growth of the companion animal segment. For instance, according to the Zebra survey, 12.8% of Americans adopted a pet in 2020.
Based on the infection type, the market has been categorized into bacterial infections, viral infections, parasitic infections, and others. Among them, the parasitic infections segment holds a prominent share of the market. This is mainly owing to the increasing number of parasitic infections such as Ehrlichiosis and helminths in animals.
For a better understanding of the market adoption of the veterinary infectious disease diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated held a dominant market share in 2020. This is mainly due to the initiative taken by governmental organizations, higher adoption of pets, and favorable pet insurance policies. For instance, as per NAPHIA's 2022 State of the Industry Report, more than 4.41 million pets were insured in North America in 2021, up from 3.45 million in 2020.
Some of the major players operating in the market are BIOMERIEUX; Heska Corporation; IDEXX; Innovative Diagnostics; INDICAL BIOSCIENCE GmbH; Neogen Corporation; Randox Laboratories Ltd.; Thermo Fisher Scientific; Virbac.; and Zoetis.